Illness	Number of cases
Fibromyalgia (M79.70)	355
Seropositive rheumatoid arthritis - Other rheumatoid arthritis with rheumatoid factor of unspecified site (M05.80)	218
Other rheumatoid arthritis - Rheumatoid arthritis without rheumatoid factor unspecified site (M06.00)	177
Somatoform disorders - Pain disorder exclusively related to psychological factors (F45.41)	137
Psoriasis (L40.5)	81
Ankylosing spondylitis of multiple sites in spine (M45.00)	64
Other systemic involvement of connective tissue - Polymyalgia rheumatica (M35.3)	61
Systemic sclerosis (M34.8)	50
Systemic sclerosis - CREST syndrome (M34.1)	49
Somatoform disorders (F45.40)	36

Top 10 treatments

Treatment	Number
Function-orientated physical exercises and uses (8-561.1)	624
Measurement of the mineral content of the bone - bone density measurement (3-900)	603
Others therapeutic procedures to influence the immune system (8-547.31)	378
Complex differential diagnostic sonography of the vascular system with quantitative evaluation (3-035)	270
Treatment by injecting a medicine into an organ or tissue, or removal of excess fluid (effusion) e.g. from the joints (8-020.5)	257
Others therapeutic procedures to influence the immune system (8-547.0)	190
Measurement of lung function in an airtight cabin - whole body plethysmography (1-710)	189
Analysis of the amount of carbon monoxide taken in and given off by the lungs (1-711)	185
Treatment with electrical currents, usually directly through the skin (8-650)	126
Examination of a joint or of a bursa by taking a sample of fluid or tissue with a needle (1-854.7)	116

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 0109

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
0	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
0	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
0	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility